Fmr LLC I Teos Therapeutics, Inc. Transaction History

Fmr LLC

$1.52 Trillion
Q2 2024

A detailed history of Fmr LLC transactions in I Teos Therapeutics, Inc. stock. As of the latest transaction made, Fmr LLC holds 2,168 shares of ITOS stock, worth $25,127. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,168

Previous 1,731 25.25%

Holding current value

$25,127

Previous $23,000 39.13%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$10.33 - $18.09 $4,514 - $7,905	437 Added 25.25%	2,168 $32,000
Q1 2024 May 13, 2024	SELL	$9.89 - $13.64 $1.38 Million - $1.91 Million	-139,811 Reduced 98.78%	1,731 $23,000
Q4 2023 Feb 13, 2024	BUY	$8.57 - $11.06 $7,533 - $9,721	879 Added 0.62%	141,542 $1.55 Million
Q3 2023 Nov 13, 2023	SELL	$10.95 - $14.6 $591 - $788	-54 Reduced 0.04%	140,663 $1.54 Million
Q2 2023 Aug 11, 2023	SELL	$12.93 - $18.05 $930,934 - $1.3 Million	-71,998 Reduced 33.85%	140,717 $1.86 Million
Q1 2023 May 11, 2023	SELL	$13.02 - $22.62 $1.85 Million - $3.22 Million	-142,283 Reduced 40.08%	212,715 $2.9 Million
Q4 2022 Feb 13, 2023	SELL	$17.77 - $21.6 $1.62 Million - $1.97 Million	-91,279 Reduced 20.45%	354,998 $6.93 Million
Q3 2022 Nov 10, 2022	BUY	$18.6 - $27.25 $280,506 - $410,957	15,081 Added 3.5%	446,277 $8.5 Million
Q2 2022 Aug 12, 2022	SELL	$16.57 - $35.1 $3.02 Million - $6.4 Million	-182,341 Reduced 29.72%	431,196 $8.88 Million
Q1 2022 May 13, 2022	SELL	$31.92 - $47.45 $5.81 Million - $8.63 Million	-181,944 Reduced 22.87%	613,537 $19.7 Million
Q4 2021 Feb 14, 2022	SELL	$26.23 - $47.86 $251,808 - $459,456	-9,600 Reduced 1.19%	795,481 $37 Million
Q3 2021 Nov 15, 2021	SELL	$23.91 - $29.58 $136,287 - $168,606	-5,700 Reduced 0.7%	805,081 $0
Q2 2021 Aug 13, 2021	BUY	$17.9 - $36.1 $14.5 Million - $29.3 Million	810,781 New	810,781 $0

Others Institutions Holding ITOS

# of Institutions

149

Shares Held

36.3M

Call Options Held

653K

Put Options Held

1.48M

View Full List

About iTeos Therapeutics, Inc.

Ticker ITOS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,575,300
Market Cap $412M
Description
Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...

More about ITOS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account